Additional file 4 of Decitabine in combination with fludarabine and cyclophosphamide as a lymphodepletion regimen followed by CD19/CD22 bispecific targeted CAR T-cell therapy significantly improves survival in relapsed/refractory B-ALL patients
收藏数据链接：
https://springernature.figshare.com/articles/dataset/Additional_file_4_of_Decitabine_in_combination_with_fludarabine_and_cyclophosphamide_as_a_lymphodepletion_regimen_followed_by_CD19_CD22_bispecific_targeted_CAR_T-cell_therapy_significantly_improves_survival_in_relapsed_refractory_B-ALL_pati/22620311/1数据链接链接失效反馈
官方服务：
资源简介：
Additional file 4. Adverse Events.
提供机构：
figshare创建时间：
2023-04-13
